Suspension of trading
Canntab Therapeutics Limited Stock Deutsche Boerse AG
Stocks
TBF1
CA1377991023
Pharmaceuticals
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000500 EUR | -.--% |
|
-.--% | - |
| 24-04-14 | Canntab Therapeutics Limited announced that it expects to receive CAD 0.1 million in funding | CI |
| 3 years | 0 |  | 0.02 |
| 5 years | 0 | | 0.6 |
| 10 years | 0 | | 1.37 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Tech/Sci/R&D Officer | - | 2020-05-14 | |
Frank Candido
IRC | Investor Relations Contact | 61 | 2018-08-31 |
Eric Malinski
SAM | Sales & Marketing | - | 2018-04-30 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 38 | |
| +1.65% | +2.37% | -12.57% | -7.09% | 12.6B | |
| +0.13% | +1.44% | -35.57% | -59.56% | 4.69B | |
| +2.30% | +6.25% | -8.93% | -11.88% | 4.35B | |
| +0.65% | -0.64% | +8.88% | -39.86% | 3.77B | |
| +2.01% | +3.08% | +15.44% | -12.90% | 3.77B | |
| -0.09% | -16.42% | -14.71% | -22.73% | 3.05B | |
| +1.18% | -0.36% | -12.36% | -5.17% | 2.99B | |
| +0.80% | +0.60% | -6.87% | -26.27% | 2.34B | |
| +3.25% | +4.19% | -8.15% | +28.39% | 1.66B | |
| Average | +1.19% | +3.99% | -8.32% | -17.45% | 4.36B | |
| Weighted average by Cap. | +1.32% | +4.10% | -9.78% | -18.33% |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- CTABF Stock
- TBF1 Stock
Select your edition
All financial news and data tailored to specific country editions
